Stockscreener 앱 받기
1.81
14.92%
0.235
시간 외 거래:
1.78
-0.03
-1.66%
전일 마감가:
$1.575
열려 있는:
$1.58
하루 거래량:
162.93K
Relative Volume:
1.60
시가총액:
$4.33M
수익:
$3.91M
순이익/손실:
$-11.65M
주가수익비율:
-0.1469
EPS:
-12.3212
순현금흐름:
$-11.51M
1주 성능:
+3.43%
1개월 성능:
-21.13%
6개월 성능:
-79.17%
1년 성능:
-88.54%
1일 변동 폭
$1.57
$1.92
1주일 범위
$1.52
$1.92
52주 변동 폭
$1.52
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
명칭
Intelligent Bio Solutions Inc
전화
646-790-5756
주소
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.81 | 4.11M | 3.91M | -11.65M | -11.51M | -12.32 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Intelligent Bio Solutions Inc 주식(INBS)의 최신 뉴스
Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Intelligent Bio Solutions Inc (INBS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Free cash flow per share of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Book value per share of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Revenue per share of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc (INBS) Institutional Confidence - TradingKey
Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
INBS|Intelligent Bio Solutions Inc|Price:1.750|Chg%:-0.060 - TradingKey
Long term debt to total equity ratio of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Total equity of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Cash flow from financing activities of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc (INBS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Gross profit of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc. Income Statement – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc (INBS) Cash Flow - TradingKey
Intelligent Bio Solutions Inc. Revenue Breakdown – NASDAQ:INBS - TradingView
Intelligent Bio Solutions Resolves Cybersecurity Issues, Prepares FDA 510(k) Submission for U.S. Drug Screening Market Expansion – Minichart - Minichart
Intelligent Bio Solutions Inc (INBS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Intelligent Bio Solutions Advances FDA 510(k) Cybersecurity Readiness - TipRanks
Intelligent Bio Solutions addresses cybersecurity issues, keeps 510(k) submission on track for H2 2026 - TradingView
INTELLIGENT BIO SOLUTIONSON TRACK FOR 510(K) SUBMISSION IN H2 2026 - Moomoo
Intelligent Bio Solutions addresses FDA cybersecurity items - Investing.com
Intelligent Bio Solutions Resolves Final Cybersecurity and Software Review Items Ahead of Planned H2 2026 510(k) Submission - Quiver Quantitative
Fingerprint Drug Test Delivers Results in Under 10 Minutes; FDA Filing Planned - Stock Titan
Intelligent Bio Solutions clears cybersecurity, software review items ahead of FDA 510(k) filing in H2 2026 - Bitget
Intelligent Bio Solutions (INBS) Drops 8% as Stock Approaches Key Support LevelVolume Weighted Price - dars.gov.et
Intelligent Bio Solutions (INBS) Completes Precision Testing for Drug Screening System - GuruFocus
Intelligent Bio Solutions completes precision t... - Pluang
Intelligent Bio Solutions Completes Precision Testing of Intelligent Fingerprinting Drug Screening System - Moomoo
Intelligent Bio Solutions completes precision testing for FDA filing By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Advances Fingerprint Drug Screening Precision - TipRanks
Intelligent Bio Solutions completes 1,600+ precision tests to bolster FDA 510(k) submission - TradingView
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market - The Manila Times
Intelligent Bio Solutions completes precision testing for FDA filing - Investing.com
Intelligent Bio Solutions Completes Precision Testing for FDA 510(k) Submission of Fingerprint Drug Screening System for Codeine Detection - Quiver Quantitative
Fingerprint Drug Screen Shows Repeatable Results in 1,600 Tests - Stock Titan
Intelligent Bio Solutions publishes investor deck on fingerprint sweat-based drug screening system - Bitget
INBS: Rapid, non-invasive fingerprint drug testing drives growth and margin gains in a $31B market - TradingView
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Morning Market Movers: BIYA, GVH, ADVB, SDOT See Big Swings - RTTNews
Intelligent Bio Solutions (INBS) Advances 4% as Stock Holds Above Key SupportBreakout Stock Alerts - dars.gov.et
Intelligent Bio Solutions Company Profile & Introduction - Moomoo
12 Information Technology Stocks Moving In Friday's Pre-Market Session - Sahm
Intelligent Bio Solutions (INBS) Holds Steady Near Midpoint of Recent RangeCall Flow Alert - dars.gov.et
Intelligent Bio Solutions (INBS) Slips 2.29% – Testing Support Levels Amid Low VolumeEnding Diagonal - dars.gov.et
Best United Kingdom Healthcare Stocks to Watch for July 2026 - Kalkine Media
Pi3g Stocks NVIDIA DGX Station And Publishes Pricing. - openPR.com
Intelligent Bio Solutions(INBS) Stock Options Chain | Quotes & News - Moomoo
Intelligent Bio Solutions (INBS) Holds Steady Near Support Amid Low VolatilityValue Factor - dars.gov.et
INBSIntelligent Bio Solutions Inc Revenue Breakdown - Finviz
INBS Q1 2025 Earnings: EPS Misses Estimates Amid Pre-Revenue Development PhasePreliminary Results - dars.gov.et
Intelligent Bio Solutions Inc (INBS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.04%
11.95%
자본화:
|
볼륨(24시간):